0001021408-24-005781.txt : 20240829 0001021408-24-005781.hdr.sgml : 20240829 20240829141105 ACCESSION NUMBER: 0001021408-24-005781 CONFORMED SUBMISSION TYPE: N-PX PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240829 EFFECTIVENESS DATE: 20240829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Johnson & Johnson Innovation - JJDC, Inc. CENTRAL INDEX KEY: 0000924020 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: N-PX SEC ACT: 1934 Act SEC FILE NUMBER: 028-20073 FILM NUMBER: 241262185 BUSINESS ADDRESS: STREET 1: 410 GEORGE STREET CITY: NEW BRUNSWICK STATE: NJ ZIP: 08901 BUSINESS PHONE: (732) 524-3218 MAIL ADDRESS: STREET 1: 410 GEORGE STREET CITY: NEW BRUNSWICK STATE: NJ ZIP: 08901 FORMER COMPANY: FORMER CONFORMED NAME: JOHNSON & JOHNSON DEVELOPMENT CORP ET AL DATE OF NAME CHANGE: 19940526 N-PX 1 primary_doc.xml N-PX IM LIVE 0000924020 XXXXXXXX false false 06/30/2024 YEAR 2024 Johnson & Johnson Innovation - JJDC, Inc. 508-692-8812

410 George Street New Brunswick NJ 08901

INSTITUTIONAL MANAGER VOTING REPORT N 028-20073 N 0 Johnson & Johnson Innovation - JJDC, Inc. Jill McManus Jill McManus Assistant Treasurer 08/29/2024 PROXY VOTING RECORD 2 proxyvote.xml Arrowhead Pharmaceuticals 04280A100 3/14/2024 Advisory Vote to Approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Senseonics Holdings, Inc. 81727U105 5/22/2024 Advisory approval of the compensation of the Company?s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Procept BioRobotics Corporation 74276L105 6/04/2024 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Aldeyra Therapeutics, Inc. 01438T106 6/04/2024 To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Adicet Bio, Inc. 007002108 6/5/2024 To ratify, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Adicet Bio, Inc. 007002108 6/5/2024 To ratify, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Marker Therapeutics, Inc. 57055L206 6/6/2024 To approve, on an advisory basis, the compensation of the Company?s named executive officers, as disclosed in this proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Xencor, Inc. 98401F105 6/13/2024 To approve,by non-binding advisory vote, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Altimmune Inc 02155H200 9/28/2023 Balloting on Proposal 3, to approve, on an advisory basis, the compensation of the Company?s named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Altimmune Inc 02155H200 9/28/2023 Balloting on Proposal 4, to approve, on an advisory basis, on the frequency of future advisory votes on the compensation of the Company?s named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Gyre Therapeutics, Inc. 403783103 8/29/2023 To approve, by non-binding advisory vote, the compensation of Catalyst?s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Gyre Therapeutics, Inc. 403783103 8/29/2023 To conduct an advisory vote on the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Standard Biotools, Inc. 34385P108 6/27/2024 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 ABSTAIN 0 NONE Meira GTx Holdings plc G59665102 6/6/2024 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6641064 0 FOR 6641064 FOR Meira GTx Holdings plc G59665102 6/6/2024 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6641064 0 1YEAR 6641064 AGAINST Fate Therapeutics, Inc. 31189P102 6/7/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3379064 0 FOR 3379064 FOR Protagonist Therapeutics Inc. 74366E102 6/20/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2449183 0 FOR 2449183 FOR